Paper39388705
Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review.
Chen J and 6 others. Biomol Biomed, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review. Papers, record 39388705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39388705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myasthenia Gravis | Major topic |
| Mitochondria | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Animals | |
| Oxidative Stress |
Source PubMed
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26414764 | Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. | Nat Immunol | 2015 | https://conductscience.org/library/papers/26414764 | PubMed |
| 2 | 28875486 | Metabolism in Immune Cell Differentiation and Function. | Adv Exp Med Biol | 2017 | https://conductscience.org/library/papers/28875486 | PubMed |
| 3 | 38570836 | Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/38570836 | PubMed |
| 4 | 32566604 | Glucose metabolism pattern of peripheral blood immune cells in myasthenia gravis patients. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/32566604 | PubMed |
| 5 | 27891095 | Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats. | Front Physiol | 2016 | https://conductscience.org/library/papers/27891095 | PubMed |
| 6 | 29669254 | Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis. | Immunity | 2018 | https://conductscience.org/library/papers/29669254 | PubMed |
| 7 | 37436042 | Biochemical and cellular basis of oxidative stress: Implications for disease onset. | J Cell Physiol | 2023 | https://conductscience.org/library/papers/37436042 | PubMed |
| 8 | 38903526 | Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis. | Front Immunol | 2024 | https://conductscience.org/library/papers/38903526 | PubMed |
| 9 | 24660594 | Protective effect of Sijunzi decoction on neuromuscular junction ultrastructure in autoimmune myasthenia gravis rats. | J Tradit Chin Med | 2013 | https://conductscience.org/library/papers/24660594 | PubMed |
| 10 | 29872094 | Effect of Qiangji Jianli decoction on mitochondrial respiratory chain activity and expression of mitochondrial fusion and fission proteins in myasthenia gravis rats. | Sci Rep | 2018 | https://conductscience.org/library/papers/29872094 | PubMed |
| 11 | 28546359 | AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System. | Circ Res | 2017 | https://conductscience.org/library/papers/28546359 | PubMed |
| 12 | 21088848 | Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. | J Neurol | 2011 | https://conductscience.org/library/papers/21088848 | PubMed |
| 13 | 30236989 | Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria. | Toxicol Appl Pharmacol | 2018 | https://conductscience.org/library/papers/30236989 | PubMed |
| 14 | 29682760 | Protective role of Parkin in skeletal muscle contractile and mitochondrial function. | J Physiol | 2018 | https://conductscience.org/library/papers/29682760 | PubMed |
| 15 | 37102669 | Conventional and emerging treatments and controversies in myasthenia gravis. | Expert Rev Neurother | 2023 | https://conductscience.org/library/papers/37102669 | PubMed |
| 16 | 25601541 | Targeting T cell metabolism for therapy. | Trends Immunol | 2015 | https://conductscience.org/library/papers/25601541 | PubMed |
| 17 | 36225188 | Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/36225188 | PubMed |
| 18 | 24556090 | Metabolism of activated T lymphocytes. | Curr Opin Immunol | 2014 | https://conductscience.org/library/papers/24556090 | PubMed |
| 19 | 32071438 | The cell biology of mitochondrial membrane dynamics. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32071438 | PubMed |
| 20 | 25135708 | Hesperidin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress in a mouse model of Alzheimer's disease. | Cell Mol Neurobiol | 2014 | https://conductscience.org/library/papers/25135708 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871075 | Comprehensive metabolomic characterization of patients with myasthenia gravis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42871075 | PubMed |
| 42174583 | Quantitative assessment of efficacy and evaluation of feasibility of exercise training protocols in adult and pediatric primary mitochondrial disease. | BMC Med | 2026 | https://conductscience.org/library/papers/42174583 | PubMed |
| 41324784 | Interconnection between myasthenia gravis and type 2 diabetes: emerging role of metformin in modulating PI3K/AKT/mTOR/AMPK axis. | Metab Brain Dis | 2025 | https://conductscience.org/library/papers/41324784 | PubMed |
| 40953299 | Redox Cascade in Chicken Skeletal Muscle: SELENOT Suppression in Selenium Deficiency Triggers Disulfidptosis via mtROS-NADPH Dysregulation. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40953299 | PubMed |
| 40843740 | Plasma Biomarkers of Mitochondrial Dysfunction in Patients with Myasthenia Gravis. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/40843740 | PubMed |
| 40688837 | A Rare Case of Myasthenia Gravis With Underlying Aldolase A Deficiency: Diagnostic and Therapeutic Challenges. | Cureus | 2025 | https://conductscience.org/library/papers/40688837 | PubMed |
| 40622977 | Circadian rhythm genes and immune cell infiltration in myasthenia gravis: A comprehensive analysis. | PLoS One | 2025 | https://conductscience.org/library/papers/40622977 | PubMed |
| 40524201 | Hypothalamic kisspeptin alleviates myasthenia gravis by regulating Th1/Th17/Treg balance through Inhibition of NF-κB signaling pathway. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/40524201 | PubMed |
| 40196119 | Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect. | Front Immunol | 2025 | https://conductscience.org/library/papers/40196119 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39388705
GET https://conductscience.org/api/papers/v1/39388705/references?page=2